References
- Liang M, Socher S, Roberts WN, Esdaile JM. Measurement of systemic lupus erythematosus activity in clinical research. Arthritis Rheum. 1998;31:817-825.
- Bombardieri C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. Arthritis Rheum. 1992;35:630-640.
- Liang M, Socher SA, Larsen MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum. 1989;32:1107-1108.
- Symmons D, Coppock J, et al. Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. QJM. 1988;69:927-932.
- Hay EM, Bacon PA, et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. QJM. 1993;86:447-458.
- Gladman DD, Goldsmith C, Urowitz MB, et al. Sensitivity to change of 3 systemic lupus disease activity indices: international validation. J Rheumatol. 1994;21:1468-1471.
- Ward MM, Marx AS, Barry NN. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus. J Rheumatol. 2000;27:664-660.
- Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the SLICC/ACR damage index for SLE. Arthritis Rheum. 1996;39:363-369.
- Garratt AM, Ruta DA, Abdalla MI, et al. The SF-36 health survey questionnaire. Br Med J. 1993;306:1440-1444.
- Isenberg DA, Garton M, Reichlin MW, Reichlin M. Long-term follow up of autoantibody profiles in black female lupus patients and clinical comparison with Caucasian and Asian patients. Brit J Rheum. 1997;36:229-233.
- Ng K, Manson JJ, Rahman A, Isenberg DA. Association of anti-nucleosome antibodies with disease flare in serologically active, clinically quiescent patients with systemic lupus erythematosus. Arthritis Care Res. 2006;55:900-904.
- Griffiths B, Emery P, et al. The BILAG multi-centre RCT comparing ciclosporin (CyA) versus azathioprine in patients with severe SLE. Arthritis Rheum. 2006;54:S789.
